Tag: Prescription Drugs
Report Reveals Extent of Cost-Related Medication Nonadherence in Seniors
3.6 percent did not get prescription medications due to cost; 3.4 percent did not take medication as prescribed due to cost
Monoclonal Antibody Tops Placebo for Reducing Migraine Frequency
Humanized mAb directed against pituitary adenylate cyclase-activating polypeptide ligand reduces migraines over four weeks
First-Generation Antihistamines Increase Risk for Seizures in Children
Highest risk seen in young children aged 6 to 24 months
Asthma Inhalers Tied to Large Greenhouse Gas Emissions Production
Metered-dose inhalers were responsible for nearly all inhaler-related emissions
SGLT-2 Inhibitors May Cut Dementia Risk in Patients With Diabetes
Findings show greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors
Cholinesterase Inhibitors Beneficial for Dementia With Lewy Bodies
Use of ChEIs significantly slowed cognitive decline at follow-ups compared with memantine and nonuse
Increasing Thiazide Dose Linked to Greater Reduction in Calcium
Cumulative incidence of symptomatic stone event decreased with increasing calcium change after thiazide prescription
Ubrogepant Administered During Prodrome Beneficial for Migraine
Greater ability to function normally, greater reduction in activity limitations, and greater rate of satisfaction seen with medication
Lecanemab-Labeled Amyloid Plaques Identified in Down Syndrome
Extensive binding of lecanemab to brain blood vessels observed in Down syndrome postmortem brain tissue analysis
Elinzanetant Efficacious, Well-Tolerated for Vasomotor Symptoms
Two phase 3 trials showed that elinzanetant reduced VMS frequency and improved VMS severity at weeks 4 and 12
